AllazoHealth was founded on the premise that each individual is unique. After building an award-winning medication adherence program used by over 14 million patients, CEO Clifford Jones realized the need for predictive analytics and individualized intervention targeting to better combat patient non-adherence. Unable to find these techniques properly utilized in any major program, Clifford brought together experts in machine learning, statistics, and medication adherence to form AllazoHealth in 2011.
Our patent-pending AllazoEngine uses the power of big data to accurately predict medication adherence patterns on a patient-by-patient basis. This approach enables our clients to deploy interventions strategically while minimizing uncertainty and risk. This combination of predictive analytics and individualized intervention targeting drives greater uplift in medication adherence while maximizing ROI. AllazoEngine is flexible and continuously learning, making us an ideal resource for any client. Our experience with clients improves the platform through machine learning and earns us key strategic partnerships with industry leaders.
We sell our services as both a stand-alone analytics solution with interventions executed by clients and a full-service solution with interventions executed by AllazoHealth’s intervention provider partners. We work with a wide range of clients and intervention providers throughout the U.S.